Two-stage matching-adjusted indirect comparison

被引:3
|
作者
Remiro-Azocar, Antonio [1 ,2 ]
机构
[1] Bayer PLC, Med Affairs Stat, 400 South Oak Way, Reading, Berks, England
[2] UCL, Dept Stat Sci, 1-19 Torrington Pl, London, England
关键词
Health technology assessment; Indirect treatment comparison; Matching-adjusted indirect comparison; Covariate adjustment; Covariate balance; Inverse probability of treatment weighting; Evidence synthesis; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANCHORED INDIRECT COMPARISONS; GUANFACINE EXTENDED-RELEASE; PROPENSITY SCORE; INVERSE PROBABILITY; CAUSAL INFERENCE; VARIABLE SELECTION; PRACTICAL GUIDE; PERFORMANCE; TRIAL;
D O I
10.1186/s12874-022-01692-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Anchored covariate-adjusted indirect comparisons inform reimbursement decisions where there are no head-to-head trials between the treatments of interest, there is a common comparator arm shared by the studies, and there are patient-level data limitations. Matching-adjusted indirect comparison (MAIC), based on propensity score weighting, is the most widely used covariate-adjusted indirect comparison method in health technology assessment. MAIC has poor precision and is inefficient when the effective sample size after weighting is small. Methods A modular extension to MAIC, termed two-stage matching-adjusted indirect comparison (2SMAIC), is proposed. This uses two parametric models. One estimates the treatment assignment mechanism in the study with individual patient data (IPD), the other estimates the trial assignment mechanism. The first model produces inverse probability weights that are combined with the odds weights produced by the second model. The resulting weights seek to balance covariates between treatment arms and across studies. A simulation study provides proof-of-principle in an indirect comparison performed across two randomized trials. Nevertheless, 2SMAIC can be applied in situations where the IPD trial is observational, by including potential confounders in the treatment assignment model. The simulation study also explores the use of weight truncation in combination with MAIC for the first time. Results Despite enforcing randomization and knowing the true treatment assignment mechanism in the IPD trial, 2SMAIC yields improved precision and efficiency with respect to MAIC in all scenarios, while maintaining similarly low levels of bias. The two-stage approach is effective when sample sizes in the IPD trial are low, as it controls for chance imbalances in prognostic baseline covariates between study arms. It is not as effective when overlap between the trials' target populations is poor and the extremity of the weights is high. In these scenarios, truncation leads to substantial precision and efficiency gains but induces considerable bias. The combination of a two-stage approach with truncation produces the highest precision and efficiency improvements. Conclusions Two-stage approaches to MAIC can increase precision and efficiency with respect to the standard approach by adjusting for empirical imbalances in prognostic covariates in the IPD trial. Further modules could be incorporated for additional variance reduction or to account for missingness and non-compliance in the IPD trial.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Correction: Two-stage matching-adjusted indirect comparison
    Antonio Remiro‑Azócar
    BMC Medical Research Methodology, 22
  • [2] A comprehensive review and shiny application on the matching-adjusted indirect comparison
    Jiang, Ziren
    Cappelleri, Joseph C.
    Gamalo, Margaret
    Chen, Yong
    Thomas, Neal
    Chu, Haitao
    RESEARCH SYNTHESIS METHODS, 2024, 15 (04) : 671 - 686
  • [3] THE USE OF MATCHING-ADJUSTED INDIRECT COMPARISON FOR ONCOLOGY SUBMISSIONS IN NICE
    Kaur, G.
    Singh, B.
    VALUE IN HEALTH, 2023, 26 (12) : S407 - S407
  • [4] EVALUATION OF MATCHING-ADJUSTED INDIRECT COMPARISON IMPLEMENTED BY A RESAMPLING METHOD
    Wang, J.
    Odom, D.
    Chirila, C.
    Zheng, Q.
    VALUE IN HEALTH, 2015, 18 (03) : A31 - A31
  • [5] MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): SENSITIVITY ANALYSES AND GRAPHICAL DIAGNOSTICS
    Signorovitch, J.
    Cao, W.
    Rybkin, V
    Yao, Z.
    Hellstern, M.
    VALUE IN HEALTH, 2017, 20 (09) : A771 - A771
  • [6] Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison
    Phillippo, David M.
    Dias, Sofia
    Ades, A. E.
    Welton, Nicky J.
    RESEARCH SYNTHESIS METHODS, 2020, 11 (04) : 568 - 572
  • [7] A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons
    Cassidy, Owen
    Harte, Marie
    Trela-Larsen, Lea
    Walsh, Cathal
    White, Arthur
    McCullagh, Laura
    Leahy, Joy
    VALUE IN HEALTH, 2023, 26 (11) : 1665 - 1674
  • [8] A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFGARTIGIMOD VERSUS RAVULIZUMAB FOR GENERALIZED MYASTHENIA GRAVIS
    Celico, L.
    Spaepen, E.
    De Francesco, M.
    Chiroli, S.
    Iannazzo, S.
    Ruck, T.
    Meuth, S. G.
    VALUE IN HEALTH, 2022, 25 (12) : S20 - S20
  • [9] WORTH THE WEIGHT: EVALUATION OF WEIGHTING STRATEGIES IN UNANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON
    Rasouliyan, L.
    Odom, D.
    VALUE IN HEALTH, 2021, 24 : S189 - S189
  • [10] Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison
    Signorovitch J.
    Swallow E.
    Kantor E.
    Wang X.
    Klimovsky J.
    Haas T.
    Devine B.
    Metrakos P.
    Experimental Hematology & Oncology, 2 (1)